Literature DB >> 23515277

Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction.

Michael R Zile1, Barbro Kjellstrom, Tom Bennett, Yong Cho, Catalin F Baicu, Mark F Aaron, William T Abraham, Robert C Bourge, Fred J Kueffer.   

Abstract

BACKGROUND: The purpose of the current study was to define exercise-induced changes in indices of left ventricular (LV) systolic and diastolic properties in patients with chronic heart failure (HF), compare these changes in patients with HF and a reduced ejection fraction (EF) versus HF and a preserved EF, and compare the hemodynamic responses to activities of daily living with symptom-limited upright exercise. METHODS AND
RESULTS: Subjects with HF and a preserved EF (n=8) and subjects with HF and a reduced EF (n=5) underwent symptom-limited Naughton protocol treadmill exercise tests. Implantable hemodynamic monitor data and echocardiographic data were obtained before exercise and at peak exercise. Implantable hemodynamic monitor data were obtained during activities of daily living during a 24-hour time period. In patients with HF and a reduced EF, limited exercise time (639±164 seconds) was associated with a marked rise in right ventricular systolic, diastolic, and estimated pulmonary artery diastolic (ePAD) pressures and an increase in LV end diastolic volume (EDV). LV systolic properties, namely EF, end systolic elastance, stroke work, and preload recruitable stroke work, all decreased. The ePAD/EDV ratio increased; to a large extent, this was dependent on an increase in EDV. By contrast, in HF and a preserved EF, limited exercise time (411±128 seconds) and the marked rise in right ventricular systolic, diastolic, and ePAD pressures were associated with no change in LV EDV. LV systolic properties increased or were unchanged; ePAD/EDV ratio increased during exercise, but the increase was independent of a change in EDV. The ranges of right ventricular systolic, diastolic, and ePAD pressures during activities of daily living were higher than the ranges of these values during the exercise stress test.
CONCLUSIONS: Although exercise limitations were similar between HF and a reduced EF and HF and a preserved EF, there were significant differences in exercise-induced changes in LV systolic and diastolic properties. These differences likely reflect the different pathophysiologies of these clinical syndromes of HF.

Entities:  

Keywords:  diastolic function; exercise; heart failure; systolic function

Mesh:

Year:  2013        PMID: 23515277     DOI: 10.1161/CIRCHEARTFAILURE.112.000216

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  16 in total

1.  Classification of Decompensated Heart Failure From Clinical and Home Ballistocardiography.

Authors:  Varol Burak Aydemir; Supriya Nagesh; Md Mobashir Hasan Shandhi; Joanna Fan; Liviu Klein; Mozziyar Etemadi; James Alex Heller; Omer T Inan; James M Rehg
Journal:  IEEE Trans Biomed Eng       Date:  2019-08-15       Impact factor: 4.538

Review 2.  Effects of exercise training on cardiac function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials.

Authors:  Hidekatsu Fukuta; Toshihiko Goto; Kazuaki Wakami; Takeshi Kamiya; Nobuyuki Ohte
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

3.  Hemodynamic Correlates and Diagnostic Role of Cardiopulmonary Exercise Testing in Heart Failure With Preserved Ejection Fraction.

Authors:  Yogesh N V Reddy; Thomas P Olson; Masaru Obokata; Vojtech Melenovsky; Barry A Borlaug
Journal:  JACC Heart Fail       Date:  2018-05-23       Impact factor: 12.035

4.  Haemodynamics, dyspnoea, and pulmonary reserve in heart failure with preserved ejection fraction.

Authors:  Masaru Obokata; Thomas P Olson; Yogesh N V Reddy; Vojtech Melenovsky; Garvan C Kane; Barry A Borlaug
Journal:  Eur Heart J       Date:  2018-08-07       Impact factor: 29.983

5.  Left ventricular concentric remodeling and impaired cardiorespiratory fitness in patients with heart failure and preserved ejection fraction.

Authors:  Justin Heizer; Salvatore Carbone; Hayley E Billingsley; Benjamin W VAN Tassell; Ross Arena; Antonio Abbate; Justin M Canada
Journal:  Minerva Cardiol Angiol       Date:  2020-09-30

Review 6.  Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction.

Authors:  Michael R Zile; Catalin F Baicu
Journal:  J Cardiovasc Transl Res       Date:  2013-05-29       Impact factor: 4.132

7.  Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.

Authors:  Selma F Mohammed; Barry A Borlaug; Steven McNulty; Gregory D Lewis; Grace Lin; Rosita Zakeri; Marc J Semigran; Martin LeWinter; Adrian F Hernandez; Eugene Braunwald; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2014-05-15       Impact factor: 8.790

8.  Correlation of serum ST2 levels with severity of diastolic dysfunction on echocardiography and findings on cardiac MRI in patients with heart failure with preserved ejection fraction.

Authors:  Vivek Agrawal; Suhas Hardas; Hasmukh Gujar; Deepak S Phalgune
Journal:  Indian Heart J       Date:  2022-03-09

9.  A new twist on an old idea: a two-dimensional speckle tracking assessment of cyclosporine as a therapeutic alternative for heart failure with preserved ejection fraction.

Authors:  Jessica A Hiemstra; Songtao Liu; Mark A Ahlman; Karl H Schuleri; Albert C Lardo; Christopher P Baines; Kevin C Dellsperger; David A Bluemke; Craig A Emter
Journal:  Physiol Rep       Date:  2013-12-05

10.  Impaired relaxation despite upregulated calcium-handling protein atrial myocardium from type 2 diabetic patients with preserved ejection fraction.

Authors:  Regis R Lamberts; Shivanjali J Lingam; Heng-Yu Wang; Ilse A E Bollen; Gillian Hughes; Ivor F Galvin; Richard W Bunton; Andrew Bahn; Rajesh Katare; J Chris Baldi; Michael J A Williams; Pankaj Saxena; Sean Coffey; Peter P Jones
Journal:  Cardiovasc Diabetol       Date:  2014-04-05       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.